3.0.0 1785 2022-11-01T07:02:34Z 2022-11-01T07:02:34Z Senate S 2019-06-11 116 ssfi00 Finance Committee Senate Standing Referred to 2019-06-11T21:23:10Z Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 116 4378 HR 2019-09-27 Became Public Law No: 116-59. Related bill CRS Fair AMP Act 116 3276 HR 2019-06-14 Referred to the Subcommittee on Health. Identical bill CRS Affordable Medications Act 116 1801 S 2019-06-12 Read twice and referred to the Committee on Finance. Related bill CRS 2019-06-11 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2019-06-11 Introduced in Senate IntroReferral 10000 9 Library of Congress H001076 Sen. Hassan, Margaret Wood [D-NH] Maggie Hassan D NH N C001075 Sen. Cassidy, Bill [R-LA] Bill Cassidy R LA 2019-06-11 True S000770 Sen. Stabenow, Debbie [D-MI] Debbie Stabenow D MI 2019-06-11 True C001056 Sen. Cornyn, John [R-TX] John Cornyn R TX 2019-06-11 True C000141 Sen. Cardin, Benjamin L. [D-MD] Ben Cardin D MD 2019-06-11 True Y000064 Sen. Young, Todd [R-IN] Todd Young R IN C. 2019-06-11 True Health Health care costs and insurance Health programs administration and funding Inflation and prices Medicaid Prescription drugs Retail and wholesale trades Health 00 2019-06-11 Introduced in Senate 2019-12-11T15:29:18Z Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act

This bill alters certain requirements and definitions under the Medicaid Drug Rebate Program relating to rebate calculations. Specifically, the bill repeals the requirement that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations.

]]> Fair AMP Act Display Title Fair AMP Act Short Title(s) as Introduced Fair AMP Act Introduced in Senate IS Short Title(s) as Introduced Fair and Accurate Medicaid Pricing Act of 2019 Introduced in Senate IS Official Title as Introduced A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes. Introduced in Senate IS Introduced in Senate 2019-06-11T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s1785is/xml/BILLS-116s1785is.xml 2019-06-11 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.